Remove 2025 Remove Kidney Disease Remove Outcomes
article thumbnail

Top 10 AI Cardiometabolic Startups to Watch in 2025 

Cardiometabolic Health Congress

This exciting overview highlights the top 10 AI-powered cardiometabolic startups poised to make significant impacts in 2025. These companies are at the forefront of innovation, driving improvements in patient outcomes and reshaping the future of healthcare delivery.

article thumbnail

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

With the holiday season approaching and fall in full swing, it’s the perfect time to reaffirm our commitment to delivering excellent care, improving patient outcomes, and making the most of every available resource. cardiometabolic health CME/CE conference: the 19th Annual CMHC. In the U.S.,

CME 96
article thumbnail

Expansion of AstraZeneca’s Flagship Health Equity Program Healthy Heart Africa

DAIC

milla1cf Fri, 06/28/2024 - 19:07 June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa , its flagship health equity initiative, to target a broader range of non-communicable diseases (NCDs), including chronic kidney disease (CKD) as well as hypertension and cardiovascular disease.